*{margin:0;padding:0;box-sizing:border-box;font-family:"ABC Diatype Trial"}body{background-color:#000}body{background-color:#0B0E1E;font-style:normal}.container{max-width:1720px;width:100%;margin:0 auto;padding:0 20px}img,svg{max-width:100%;height:auto}li{list-style:none;display:block}a{text-decoration:none;display:inline-block}button{background-color:transparent;outline:none;border:none}main{padding-top:150px}::placeholder{color:#FFFFFF}.sec__heading{font-weight:800;font-size:clamp(41px, 5vw, 67px);line-height:clamp(51px, 6vw, 80px);color:#FFFFFF}.sec__brief{font-weight:bold;font-size:clamp(16px, 4vw, 41px);line-height:clamp(20px, 6vw, 70px);color:#BABFC5}.primary-btn{color:#FFFFFF;font-weight:500;line-height:clamp(20px, 3vw, 36px);font-size:clamp(16px, 2vw, 25px);padding:12px 25px;background:#2940D3;box-shadow:0px 4px 4px rgba(0,0,0,0.25);border-radius:5px}
